Seeking Alpha

V.P. » Comments » Single Comment |

  • MannKind: No Partnership Likely for Inhalable Insulin [View article]
    What happened to Kos Pharmaceutical's Inhaled Insulin product, KI02212? I have not heard any news on the development of this product post the acquisiton of Kos by Abbott Labs.
    Apr 14 05:21 am |Rating: 0 0
All Comments by V.P. »
Comments by Ticker
V.P.'s
Comments Stats
3 comments
Rating: 0 (0 - 0 )